CGON
CG Oncology·NASDAQ
--
--(--)
--
--(--)
3.69 / 10
Netural
The company exhibits concerning fundamental metrics (3.7/10). Strengths observed in Interest coverage ratio (EBIT / Interest expense) (%) and Asset-MV, although drawbacks are visible in Total operating revenue (YoY growth rate %) and Operating revenue (YoY growth rate %). Lead to prudent appraisal.
Analysis Checks(6/10)
Revenue-MV
Value-5.39
Score1/3
Weight9.43%
1M Return4.24%
Value-5.39
Score1/3
Weight9.43%
1M Return4.24%
Days sales outstanding
Value40.47
Score0/3
Weight-8.30%
1M Return-5.18%
Value40.47
Score0/3
Weight-8.30%
1M Return-5.18%
Net income-Revenue
Value-0.17
Score2/3
Weight18.76%
1M Return8.45%
Value-0.17
Score2/3
Weight18.76%
1M Return8.45%
Interest coverage ratio (EBIT / Interest expense) (%)
Value15.48
Score2/3
Weight-1.87%
1M Return-1.11%
Value15.48
Score2/3
Weight-1.87%
1M Return-1.11%
Asset-MV
Value-0.50
Score2/3
Weight24.16%
1M Return10.15%
Value-0.50
Score2/3
Weight24.16%
1M Return10.15%
Total operating revenue (YoY growth rate %)
Value151.54
Score1/3
Weight-1.37%
1M Return-0.79%
Value151.54
Score1/3
Weight-1.37%
1M Return-0.79%
Profit-MV
Value0.46
Score2/3
Weight18.74%
1M Return8.45%
Value0.46
Score2/3
Weight18.74%
1M Return8.45%
PB-ROE
Value3.16
Score2/3
Weight23.37%
1M Return9.14%
Value3.16
Score2/3
Weight23.37%
1M Return9.14%
Operating revenue (YoY growth rate %)
Value151.54
Score1/3
Weight-1.32%
1M Return-0.76%
Value151.54
Score1/3
Weight-1.32%
1M Return-0.76%
Cash-MV
Value-0.07
Score2/3
Weight18.42%
1M Return8.41%
Value-0.07
Score2/3
Weight18.42%
1M Return8.41%
Revenue-MV
Value-5.39
Score1/3
Weight9.43%
1M Return4.24%
Value-5.39
Score1/3
Weight9.43%
1M Return4.24%
Total operating revenue (YoY growth rate %)
Value151.54
Score1/3
Weight-1.37%
1M Return-0.79%
Value151.54
Score1/3
Weight-1.37%
1M Return-0.79%
Days sales outstanding
Value40.47
Score0/3
Weight-8.30%
1M Return-5.18%
Value40.47
Score0/3
Weight-8.30%
1M Return-5.18%
Profit-MV
Value0.46
Score2/3
Weight18.74%
1M Return8.45%
Value0.46
Score2/3
Weight18.74%
1M Return8.45%
Net income-Revenue
Value-0.17
Score2/3
Weight18.76%
1M Return8.45%
Value-0.17
Score2/3
Weight18.76%
1M Return8.45%
PB-ROE
Value3.16
Score2/3
Weight23.37%
1M Return9.14%
Value3.16
Score2/3
Weight23.37%
1M Return9.14%
Interest coverage ratio (EBIT / Interest expense) (%)
Value15.48
Score2/3
Weight-1.87%
1M Return-1.11%
Value15.48
Score2/3
Weight-1.87%
1M Return-1.11%
Operating revenue (YoY growth rate %)
Value151.54
Score1/3
Weight-1.32%
1M Return-0.76%
Value151.54
Score1/3
Weight-1.32%
1M Return-0.76%
Asset-MV
Value-0.50
Score2/3
Weight24.16%
1M Return10.15%
Value-0.50
Score2/3
Weight24.16%
1M Return10.15%
Cash-MV
Value-0.07
Score2/3
Weight18.42%
1M Return8.41%
Value-0.07
Score2/3
Weight18.42%
1M Return8.41%
Is CGON fundamentally strong?
- CGON scores 3.69/10 on fundamentals and holds a Fair valuation at present. Backed by its -16.85% ROE, -6967.99% net margin, -26.82 P/E ratio, 5.91 P/B ratio, and 62.04% earnings growth, these metrics solidify its Netural investment rating.
